Update to Early Warning Report for Acerus Pharmaceuticals Corporation

TORONTO, June 21 2016 /CNW/ - Mr. Eugene Melnyk announced today that he sold 1,463,365 common shares of Acerus Pharmaceuticals Corporation (TSX: ASP) ("Acerus"), on June 9, 2016, through the facilities of the Toronto Stock Exchange.  Between July 25, 2014 and June 9, 2016, Mr. Melnyk sold a total of 13,497,365 common shares at prices ranging from $0.08 to $0.62 per share for aggregate consideration of $3,431,427.28.  Immediately after his June 9, 2016 sale, Mr. Melnyk owned 20,913,418 common shares, representing 9.8% of the outstanding common shares of Acerus.  Immediately prior to that sale, he owned 22,376,783 common shares, representing 10.5% of the outstanding common shares.

The shares were sold by Mr. Melnyk for investment purposes.  Depending on market conditions and other factors, Mr. Melnyk may from time to time acquire or dispose of additional securities of Acerus, in the open market, by private agreement or otherwise.

In connection with this news release, an early warning report will be filed by Mr. Melnyk in accordance with applicable securities laws. 

SOURCE Eugene Melnyk

A copy of that early warning report will be available on SEDAR at www.sedar.com and can be obtained from: Ken Villazor, 1000 Palladium Drive, Kanata, Ontario, K2V 1A5, Email: [email protected]